Fundz

Akura Medical, A Shifamed Portfolio Company, Closes $35M In Series B Financing

PRIVATEOct 03, 2023

Amount Raised

$35 Million

Round Type

Series B

Los GatosFinancial ServicesMobileHealth Care

Investors

Unorthodox VenturesLilly Asia VenturesPa Med Tech Vc FundAmed VenturesShifamed Angel InvestorsThe Capital PartnershipCormorant Asset Management

Description

Akura Medical, a Shifamed portfolio company focused on a differentiated approach to effectively address the major challenges of venous thromboembolism (VTE), announced today the closing of its $35M Series B financing. The funds will be used to apply for FDA 510(k) clearance for the Akura Mechanical Thrombectomy Platform, support clinical trials for additional indications, and scale manufacturing capabilities. The financing was led by The Capital Partnership (TCP) and Cormorant Asset Management, with significant participation from the PA MedTech VC Fund, AMED Ventures, Lilly Asia Ventures, Unorthodox Ventures and Shifamed angel investors.

Quick answer

Akura Medical raised $35 Million in a Series B round, dated October 3, 2023. Investors: Unorthodox Ventures, Lilly Asia Ventures, Pa Med Tech Vc Fund, Amed Ventures, Shifamed Angel Investors, The Capital Partnership and Cormorant Asset Management. Akura Medical is based in Los Gatos, California, United States.

How much did Akura Medical raise?
Akura Medical raised $35 Million in a Series B round on October 3, 2023.
Who invested in Akura Medical?
Unorthodox Ventures, Lilly Asia Ventures, Pa Med Tech Vc Fund, Amed Ventures, Shifamed Angel Investors, The Capital Partnership and Cormorant Asset Management are named as investors in this round.
What does Akura Medical do?
Akura Medical, a privately held portfolio company of Shifamed LLC, is a medical technology company dedicated to addressing venous thromboembolism (VTE).
Where is Akura Medical based and how big is it?
Akura Medical is based in Los Gatos, California, United States. Fundz records about 30 employees.
Who are the decision-makers at Akura Medical?
Fundz holds 1 contact at Akura Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Financial Services and Mobile around the same time

Companies in the same sectors as Akura Medical that raised within 45 days of this round, from Fundz verified event records.

  • Route 92 Medical raised $31M (Series F) on November 16, 2023.
  • Route 92 Medical raised $31M on November 15, 2023.
  • Kinto raised $5M (Funding Round) on November 15, 2023.
  • Bright Uro raised $29M on November 14, 2023.
  • QI Tech raised $200M (Funding Round) on October 31, 2023.
  • Pair Team raised $9M (Series A) on October 19, 2023.

Who to call at Akura Medical, and when

A new round usually means Akura Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akura Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akura Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akura Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akura Medical

Location

170 Knowles Dr

Los Gatos, California, United States

About

Akura Medical, a privately held portfolio company of Shifamed LLC, is a medical technology company dedicated to addressing venous thromboembolism (VTE). Our flagship product, the Katana™ Thrombectomy System, is poised to redefine pulmonary embolism (PE) treatment standards by enabling removal of diverse clot types more efficiently. The Katana Thrombectomy System embodies our mission to reshape the landscape of VTE care and make a lasting impact on the lives of patients worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akura Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Akura Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Akura Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.